Interrelationship with CAPA, Change Control, Adverse Event Reporting, Recalls and Life Cycle Process Activities.
The purpose of a regulatory inspection is to ensure that your facility is in compliance with FDA rules and regulations. Investigators want to know that product was manufactured appropriately and that the current Good Manufacturing Practices are up to FDA standard. An inspection can be very intimidating to all involved, but it is vital if you want an inspection that results in a satisfactory report.
The FDA consistently has focused on complaints as part of post market surveillance. Numerous citations are related to deficiencies and lack of implementation or effective implementation of complaint handling activities, documentation, and the disconnect between complaints with CAPA/change control/adverse event reporting/recalls. Regulated companies don’t always establish and implement a unified approach to these regulated systems.
This accredited course is intended to help you better understand and get familiar with the requirements for complaint files and key requirements of:
In addition, the course will incorporate the complaint handling life-cycle process and an example of activities involved in this life cycle.
Furthermore, this webinar will discuss complaint handling implementation challenges, in addition to pitfall challenges. At the end of this course, there will be a conclusion section, where points to take into account with the integration of CAPA/change control/adverse event reporting/recalls/complaint files in the complaint handling life-cycle, will be detailed.
Upon completion of this course, you will be able to:
This training is part of a 10 course (15 hour) series required for the FDA Inspection Readiness Certification. Attend this training as a step in the certification process or as a stand-alone course for personal career advancement and training.
You will be redirected to our secure system.
This course will be valuable to all individuals working within or managing a manufacturing program that supports either the R&D development of a new drug product or the manufacture of commercial drug product released to the market and would be beneficial to professionals in:
Regulatory affairs personnel as well as individuals who are responsible for the review or audit of such inspections and reports would likewise find this course very worthwhile.
When you need on-site attention, we’re not just here to help, we’re there to help—right by your side.
Individual courses are remarkably effective. But sometimes when you have a specific need, it helps to have expert guidance right in the room with you and your team.
In that case, we’re happy to design a custom training for your entire team, whether online—or on-site.Learn more
Capturing Justifications in Change Control, Risk Assessment, Validations, and Investigations
We’ve rebranded! CfPA is now COBBLESTONE